Editorial-Current Insights on Lipid-Based Nanosystems

Ana Catarina Silva; João Nuno Moreira; José Manuel Sousa Lobo

doi:10.3390/ph15101267

Editorial-Current Insights on Lipid-Based Nanosystems

Pharmaceuticals (Basel). 2022 Oct 14;15(10):1267. doi: 10.3390/ph15101267.

Authors

Ana Catarina Silva^{1

2}, João Nuno Moreira^{3

4}, José Manuel Sousa Lobo¹

Affiliations

¹ UCIBIO/REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
² FP-I3ID (Instituto de Investigação, Inovação e Desenvolvimento), FP-BHS (Biomedical and Health Sciences Research Unit), Faculty of Health Sciences, University Fernando Pessoa, 4249-004 Porto, Portugal.
³ CNC-Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine (Polo 1), University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal.
⁴ Pólo das Ciências da Saúde, Faculty of Pharmacy, CIBB, Univ. Coimbra-University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.

Abstract

Lipid-based nanosystems, including solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC), cationic lipid nanoparticles, nanoemulsions and liposomes, have been extensively studied to improve drug delivery through different administration routes [...].

Publication types

Editorial

Grants and funding

The Applied Molecular Biosciences Unit—UCIBIO, which is financed by national funds from Fundação para a Ciência e a Tecnologia—FCT (UIDP/04378/2020 and UIDB/04378/2020), supported this work.